Cronos Group (CRON) stock Forecast for 2022 – 2026
Last update: 05-20-2022, 6:29Sector: Healthcare
The share price of Cronos Group Inc. (CRON) now
What analysts predict:: $4.84
52-week high/low: $9.42 / $2.82
50/200 Day Moving Average: $3.367 / $4.624
This figure corresponds to the average price over the previous 50/200 days. For Cronos Group stocks, the 50-day moving average is the support level today.
For Cronos Group stocks, the 200-day moving average is the resistance level today.
Are you interested in Cronos Group Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Cronos Group stock price in 2022, 2023, 2024, 2025, 2026. How much will one Cronos Group share be worth in 2022 - 2026?
When should I take profit in Cronos Group stock? When should I record a loss on Cronos Group stock? What are analysts' forecasts for Cronos Group stock? What is the future of Cronos Group stock?
We forecast Cronos Group stock performance using neural networks based on historical data on Cronos Group stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Cronos Group stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Cronos Group shares. This happens once a day.
Historical and forecast chart of Cronos Group stock
The chart below shows the historical price of Cronos Group stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Cronos Group stock price can be found in the table below.
Long-term forecasts by years.
Cronos Group daily forecast for a month
Cronos Group Daily Price Targets
Cronos Group Stock Forecast 05-22-2022.
Pessimistic target level: 3.48
Optimistic target level: 3.57
Cronos Group Stock Forecast 05-23-2022.
Pessimistic target level: 3.45
Optimistic target level: 3.54
Cronos Group Stock Forecast 05-24-2022.
Pessimistic target level: 3.47
Optimistic target level: 3.54
Cronos Group Stock Forecast 05-25-2022.
Pessimistic target level: 3.34
Optimistic target level: 3.44
Cronos Group Stock Forecast 05-26-2022.
Pessimistic target level: 3.43
Optimistic target level: 3.53
Cronos Group Stock Forecast 05-27-2022.
Pessimistic target level: 3.48
Optimistic target level: 3.59
CRON (CRON) Monthly Stock Prediction for 2022
Cronos Group forecast for this year
Cronos Group Stock Prediction for Jun 2022
An uptrend is forecast for this month with an optimal target price of $3.8416. Pessimistic: $3.42. Optimistic: $4.01
Cronos Group Stock Prediction for Jul 2022
An uptrend is forecast for this month with an optimal target price of $4.00295. Pessimistic: $3.61. Optimistic: $4.42
Cronos Group Stock Prediction for Aug 2022
An downtrend is forecast for this month with an optimal target price of $3.84683. Pessimistic: $3.71. Optimistic: $4.02
Cronos Group Stock Prediction for Sep 2022
An uptrend is forecast for this month with an optimal target price of $4.10649. Pessimistic: $3.72. Optimistic: $4.47
Cronos Group Stock Prediction for Oct 2022
An uptrend is forecast for this month with an optimal target price of $4.34056. Pessimistic: $3.85. Optimistic: $4.82
Cronos Group Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $4.77679. Pessimistic: $4.46. Optimistic: $5.32
Cronos Group Stock Prediction for Dec 2022
An downtrend is forecast for this month with an optimal target price of $4.4257. Pessimistic: $4.17. Optimistic: $4.71
Cronos Group (CRON) Monthly Stock Prediction for 2023
Cronos Group (CRON) Monthly Stock Prediction for 2024
Cronos Group (CRON) Monthly Stock Prediction for 2025
Cronos Group (CRON) Monthly Stock Prediction for 2026
Cronos Group information and performance
Cronos Group Inc is a cannabinoid company. The company is focused on cannabis research, technology and product development. The company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones and PEACE +. PEACE NATURALS is a global wellness platform. KOUV and spinach are brands for adults. Lord Jones and MIR + are hemp-derived cannabidiol (CBD) brands. The company’s segments include the United States and the Rest of the World. The United States segment consists of the production and distribution of hemp-infused CBD-infused products. The rest of the world operates a segment involved in the cultivation, production and marketing of cannabis and cannabis-derived products for the medical and adult use markets. Subsidiaries of the company include Cronos Israel G. S. Cultivations Ltd, Cronos Israel G. S. Manufacturing Ltd, Cronos Israel G. S. Store Ltd and Cronos Israel G. S. Pharmacies Ltd.
Cronos Group Address
111 PETER STREET, SUITE 300, TORONTO, ON, CA
Market Capitalization: 1 228 372 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: - $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: 0.144
Quarterly Revenue Growth YOY: 0.513
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 2.15
Enterprise Value (EV) /Revenue
EV To EBITDA: -
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 375579000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.